Precision Medicine Platform : Personalized Immunotherapy and TiME Monitoring

Booth No: N915

Characteristic

We are the first commercial Patient-Derived Explants (PDEs) platform used for profiling the response assessment and selection to cancer immunotherapy by developed of the single cell functional multi-omics analytical modules.
If the cellular and molecular properties of the metastatic are seed the same across different tumor types and metastatic sites, a lineage analysis technique are required to quantify the fraction of single-cell versus multicellular immune cell and tumor microenvirment (TiME) analyses to determine their molecular properties. To provide a total solution, we are accelerating the discovery of identification & pathogenesis in reproductive medicine and oncology by revealing the true functional biology of every patient rare cell and it’s related immuno-microenvironment by our unique Patient-Derived Organoids (PDOs) platform to predict the cancer metastasis and recurrence in patients with lung adenocarcinoma as the first target topic.
The features of the Cell Envision SACA monitoring system include:
● Liquid biopsy – Only 4ml of blood is needed for analysis
● Simultaneous analysis of multiple cancer cell types - Circulating tumor cancer cells, cancer cell clusters, immune cells and cancer cell conjugated, and more can be analyzed.
● High accuracy - The predicted success rate is 8 times higher than that of CEA or CA 199 monitoring alone
● Ease of use – Single cancer cells can be isolated to the genetic testing platform